article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

article thumbnail

Advanced therapy collaboration network launched in Scotland

European Pharmaceutical Review

The Cell and Gene Therapy Catapult (CGT Catapult) , supported by Scotland’s national economic development agency, Scottish Enterprise, has launched a new cooperative network to foster collaboration and increase knowledge sharing across the Advanced Therapy Medicinal Products (ATMP) industry in Scotland.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The role of outsourcing in antibody drug manufacture

European Pharmaceutical Review

Other factors were listed related to the development process of inter-organisational collaboration networks in the R&D of mAbs. Findings included: “the size and complexity of the collaborative network continuously increased as dedicated biotech firms established new partnerships with existing pharmaceutical companies”.

article thumbnail

XG(S)-PON: A Technical Overview and Patent Landscape

Clarivate

To address this requirement, different standardization bodies have been working to define and upgrade technical standard specifications related to telecommunication and networking. Since the beginning of this decade, Gigabit-capable Passive Optical Network (GPON) technologies have revolutionized networks by providing faster internet services.

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

Founder: Graham Gardner Year of Establishment: 2010 Headquarters: Boston, Massachusetts. Founder: Grant Verstandig Year of establishment: 2010 Headquarters: Washington, DC. Founder: Jeff Tangney Year of establishment: 2010 Headquarters: San Francisco, California. In doing so, it helps to make each cancer patient’s story count.

article thumbnail

Biopharma could reap benefits from SVB UK acquisition

European Pharmaceutical Review

billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing. However, the acquisition of Silicon Valley Bank UK by HSBC could provide greater access for biopharmaceutical startups to international markets and global networks of investors.

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Initiatives in the UK such as the Clinical Practice Research Datalink (CPRD), The Health Improvement Network (THIN) and OpenSAFELY support UK, European, and international studies. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). EMA/95098/2010. 2018; 8(1). cited Dec2023].

Medicine 116